Ventac Partners
Dennis Henriksen is an accomplished executive with extensive experience in the life sciences sector. Currently serving as the Chief Executive Officer of Cenexum, Henriksen focuses on developing innovative implantable devices for bio-inspired data processing and neurostimulation. As Chief Technology Officer at WntResearch AB and former Chief Technology Officer at Idogen AB, Henriksen contributed to significant advancements in treatment strategies for autoimmune diseases and transplant rejection. As a Managing Partner at DBH BION, Henriksen offers expert management consulting for biotech and pharmaceutical firms. Previous leadership roles include CEO of Sanos Bioscience and VP of R&D at Nordic Bioscience, where Henriksen oversaw a range of projects from R&D to clinical development. Henriksen holds a Ph.D. in Bioorganic Chemistry from the University of Copenhagen and an M.Sc. in Chemical Engineering from The Technical University.
This person is not in the org chart
This person is not in any offices
Ventac Partners
1 followers
With offices across Europe, United States and Asia and with our multi-disciplinary Partner and Advisor teams, Ventac Partners strives to provide its clients superior global services delivered locally. Covering Biotech, Pharma and Medtech, we offer hands-on experience and skills required to drive innovative technology-based projects from the laboratory to the market. Over the last 15 years, we have experienced a steadily growing business with industry and academic institutions, we have founded, incorporated and exited several companies together with our partners and investors and consulted on hundreds of different early stage or advanced projects. Ventac Partners is continuously expanding its international presence and remains committed to generate value to its clients and portfolio company partners and investors.